NL-OMON47659已完成4 期
A rotation study of different albuminuria lowering drug classes to study individual drug response in diabetes - ROTATE-2
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •* Type 2 diabetes
- •* eGFR > 45ml/min/1.73m2
- •* Albumin:creatinine ratio >30mg/g and *500 mg/g
- •* Age * 18 years
- •* Written informed consent
排除标准
- •* Pregnant women and women of child-bearing potential who are not using
- •reliable contraception
- •* Use of GLP1 receptor agonist (exenatide, liraglutide, lixisenatide,
- •dulaglutide)
- •* Cardiovascular disease: myocardial infarction, angina pectoris,
- •percutanous transluminal coronary angioplasty, coronary artery bypass
- •grafting, stroke, heart failure (NYHA I-IV) < 6 months before inclusion
- •* Uncontrolled blood pressure (office bp > 160/ 100 mmHg)
- •* Known malignancy
- •* History of autonomic dysfunction (e.g. history of fainting or clinically
- •significant orthostatic hypotension)
- •* Any medication, surgical or medical condition which might significantly alter
- •the absorption, distribution, metabolism, or excretion of medications
研究者
相似试验
尚未招募
4 期
Comparing Medications for Reducing Kidney Damage in Diabetes: A Study on Dapagliflozin Alone and with EplerenoneCTRI/2024/01/061952Dr Nikhil Kumar
尚未招募
不适用
Rotation for Optimal Targeting of Albuminuria and Treatment EvaluatioType 2 diabetes and albuminuriaNL-OMON26322niversity Medical Center Groningen52
进行中（未招募）
1 期
A rotation study of different albuminuria lowering drug classes to study individual drug response in diabetic and non diabetic Chronic Kideny DiseaseEUCTR2017-004641-25-ESniversity Medical Center Groningen46
进行中（未招募）
1 期
A rotation study of different albuminuria lowering drug classes to study individual drug response in diabetesType 2 diabetes with albuminuriaEUCTR2015-005113-73-NLniversity Medical Center Groningen52
已完成
4 期
Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-1)Albuminuria in patients with diabetes10029149NL-OMON43438niversitair Medisch Centrum Groningen17